Study Stopped
Study did not progress to approval process, and did not open.
Postnatal Prevalence of Bacteriuria in Women With Catheter Versus no Catheter in Labour
1 other identifier
observational
N/A
0 countries
N/A
Brief Summary
Catheterisation is an accepted tool in intrapartum bladder care and indwelling catheters are used routinely before elective caesarean sections. However, urinary catheters are associated with an increased rate of urinary tract infections which can lead to complications including increased maternal morbidity and prolonged hospital stay. A Cochrane Review (2014) concluded that there is insufficient evidence to assess the routine use of indwelling bladder catheters in women undergoing caesarean section. The incidence and causation of catheter-associated infection in this population is unknown. We propose to provide this data, by comparing urine samples from pregnant women before and after their delivery and analysing this against observational catheter use during the delivery. This will be vital in conducting future research into potential change in policy on routine catheterisation. It will also be beneficial to patients as it could reduce the burden of catheterisation by reducing their chance of developing a UTI and by reducing the associated morbidity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started May 2019
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 11, 2019
CompletedFirst Posted
Study publicly available on registry
April 16, 2019
CompletedStudy Start
First participant enrolled
May 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2019
CompletedMarch 27, 2026
March 1, 2026
3 months
April 11, 2019
March 23, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Postpartum Urinary Tract Infection
Number of patients diagnosed with a postpartum urinary tract infection within 30 days of delivery. (This is defined as positive MSU (\>107 cfu/l) with associated symptoms.)
30 days post delivery
Secondary Outcomes (1)
Postpartum asymptomatic bacteriuria
30 days post delivery
Study Arms (4)
Normal Vaginal Delivery
The group of patients who achieved a normal delivery will be retrospectively assessed as to whether they had any episode of catheter insertion during their delivery.
Insturmental Vaginal Delivery
The group of patients who underwent instrumental delivery (ventouse or forceps) will be retrospectively assessed as to whether they had any episode of catheter insertion during their delivery.
Emergency Caesarean Section
Each patient will be recorded how many catheter episodes occurred during their labour and delivery.
Elective Caesarean Section
We expect all patients in this group to have an indwelling catheter sited before their elective caesarean sections, however we will assess each patient individually to confirm whether they had a catheter for their delivery.
Interventions
A data collection sheet will be assigned for every patient who is recruited for the study. The clinician caring for the patient will be asked to fill in this form after the delivery has occurred. The form essentially will describe if the patient received any catheter during the delivery and if so, an indwelling catheter or an intermittent (in/out) catheter and how many episodes this occurred.
Eligibility Criteria
The target of recruitment is pregnant women from 37 weeks gestation. They will be recruited from the Maternity Triage Department, Antenatal Clinic, Central Delivery Suite, Birth Unit or the Maternity Ward.
You may qualify if:
- Participant is willing and able to give informed consent for participation in the study
- Intact membranes
- At least 37 weeks pregnant
You may not qualify if:
- History of microbiologically-confirmed bacteriuria in preceding 28 days
- Patients who are in active labour
- Women who have had either urine-specific or broad-spectrum antibiotics within the last 28 days
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Biospecimen
Patients are asked to provide 3 samples of urine which are to be processed in the laboratory with routine testing for microscopy, culture and sensitivity and disposed of in the standard way.
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mark James, MbChb
Gloucestershire NHS Foundation Trust
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 11, 2019
First Posted
April 16, 2019
Study Start
May 1, 2019
Primary Completion
August 1, 2019
Study Completion
August 1, 2019
Last Updated
March 27, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share
Patient information will be kept confidentially and not shared as per the Data Protection Act 2018